Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome

Objectives: High cystatin C(CysC) levels are associated with impaired cardiovascular outcome. Whether CysC levels are independently related to the atherosclerosis burden is still controversial. Methods: We enrolled 31 non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous...

Full description

Bibliographic Details
Main Authors: Nevio Taglieri, Cristina Nanni, Gabriele Ghetti, Rachele Bonfiglioli, Francesco Saia, Francesco Buia, Giacomo Maria Lima, Valeria Marco, Antonio Giulio Bruno, Francesco Prati, Stefano Fanti, Claudio Rapezzi
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/9/4/657
id doaj-1e26c627e2264f53a2d034da2eac87e7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Nevio Taglieri
Cristina Nanni
Gabriele Ghetti
Rachele Bonfiglioli
Francesco Saia
Francesco Buia
Giacomo Maria Lima
Valeria Marco
Antonio Giulio Bruno
Francesco Prati
Stefano Fanti
Claudio Rapezzi
spellingShingle Nevio Taglieri
Cristina Nanni
Gabriele Ghetti
Rachele Bonfiglioli
Francesco Saia
Francesco Buia
Giacomo Maria Lima
Valeria Marco
Antonio Giulio Bruno
Francesco Prati
Stefano Fanti
Claudio Rapezzi
Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
Applied Sciences
cystatin C
<sup>18</sup>F-fluorodeoxyglucose-positron emission tomography
frequency domain-optical coherence tomography
coronary artery calcium score
non-ST-segment elevation acute coronary syndrome
author_facet Nevio Taglieri
Cristina Nanni
Gabriele Ghetti
Rachele Bonfiglioli
Francesco Saia
Francesco Buia
Giacomo Maria Lima
Valeria Marco
Antonio Giulio Bruno
Francesco Prati
Stefano Fanti
Claudio Rapezzi
author_sort Nevio Taglieri
title Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
title_short Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
title_full Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
title_fullStr Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
title_full_unstemmed Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary Syndrome
title_sort multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in non-st-segment elevation acute coronary syndrome
publisher MDPI AG
series Applied Sciences
issn 2076-3417
publishDate 2019-02-01
description Objectives: High cystatin C(CysC) levels are associated with impaired cardiovascular outcome. Whether CysC levels are independently related to the atherosclerosis burden is still controversial. Methods: We enrolled 31 non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention. Patients were divided into 2 groups on the basis of median value of serum CysC. Using the high CysC group as a dependent variable, univariable and multivariable analyses were used to evaluate the association between CysC and three different features of atherosclerosis: 1) coronary plaque vulnerability as assessed by optical coherence tomography (OCT), 2) coronary artery calcium (CAC) by means of computed tomography scan, and 3) aortic wall metabolic activity, as assessed using <sup>18</sup>F-Fluorodeoxyglucose-positron emission tomography (<sup>18</sup>F-FDG-PET). Results: After univariable and multivariable analyses, <sup>18</sup>F-FDG uptake in the descending aorta (DA) was independently associated with a low level of CysC [(Odds Ratio = 0.02; 95%CI 0.0004&#8315;0.89; p = 0.044; <sup>18</sup>F-FDG uptake measured as averaged maximum target to blood ratio); (Odds Ratio = 0.89; 95%CI 0.82&#8315;0.98, p = 0.025; <sup>18</sup>F-FDG uptake measured as number of active slices)]. No trend was found for the association between CysC and characteristics of OCT-assessed coronary plaque vulnerability or CAC score. Conclusions: In patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), <sup>18</sup>F-FDG uptake in the DA was associated with a low level of serum CysC. There was no relation between CysC levels and OCT-assessed coronary plaque vulnerability or CAC score. These findings suggest that high levels of CysC may not be considered as independent markers of atherosclerosis.
topic cystatin C
<sup>18</sup>F-fluorodeoxyglucose-positron emission tomography
frequency domain-optical coherence tomography
coronary artery calcium score
non-ST-segment elevation acute coronary syndrome
url https://www.mdpi.com/2076-3417/9/4/657
work_keys_str_mv AT neviotaglieri multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT cristinananni multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT gabrieleghetti multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT rachelebonfiglioli multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT francescosaia multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT francescobuia multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT giacomomarialima multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT valeriamarco multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT antoniogiuliobruno multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT francescoprati multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT stefanofanti multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
AT claudiorapezzi multiimaginginvestigationtoevaluatetherelationshipbetweenserumcystatincandfeaturesofatherosclerosisinnonstsegmentelevationacutecoronarysyndrome
_version_ 1724916141924548608
spelling doaj-1e26c627e2264f53a2d034da2eac87e72020-11-25T02:11:08ZengMDPI AGApplied Sciences2076-34172019-02-019465710.3390/app9040657app9040657Multi-Imaging Investigation to Evaluate the Relationship between Serum Cystatin C and Features of Atherosclerosis in Non-ST-Segment Elevation Acute Coronary SyndromeNevio Taglieri0Cristina Nanni1Gabriele Ghetti2Rachele Bonfiglioli3Francesco Saia4Francesco Buia5Giacomo Maria Lima6Valeria Marco7Antonio Giulio Bruno8Francesco Prati9Stefano Fanti10Claudio Rapezzi11Polo Cardio-Toraco-Vascolare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyIstituto di Medicina Nucleare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyPolo Cardio-Toraco-Vascolare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyIstituto di Medicina Nucleare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyPolo Cardio-Toraco-Vascolare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyIstituto di Radiologia, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyIstituto di Medicina Nucleare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyCLI Foundation, 00182 Rome, ItalyPolo Cardio-Toraco-Vascolare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyCLI Foundation, 00182 Rome, ItalyIstituto di Medicina Nucleare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyPolo Cardio-Toraco-Vascolare, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Alma Mater Studiorum Università di Bologna, 40138 Bologna, ItalyObjectives: High cystatin C(CysC) levels are associated with impaired cardiovascular outcome. Whether CysC levels are independently related to the atherosclerosis burden is still controversial. Methods: We enrolled 31 non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention. Patients were divided into 2 groups on the basis of median value of serum CysC. Using the high CysC group as a dependent variable, univariable and multivariable analyses were used to evaluate the association between CysC and three different features of atherosclerosis: 1) coronary plaque vulnerability as assessed by optical coherence tomography (OCT), 2) coronary artery calcium (CAC) by means of computed tomography scan, and 3) aortic wall metabolic activity, as assessed using <sup>18</sup>F-Fluorodeoxyglucose-positron emission tomography (<sup>18</sup>F-FDG-PET). Results: After univariable and multivariable analyses, <sup>18</sup>F-FDG uptake in the descending aorta (DA) was independently associated with a low level of CysC [(Odds Ratio = 0.02; 95%CI 0.0004&#8315;0.89; p = 0.044; <sup>18</sup>F-FDG uptake measured as averaged maximum target to blood ratio); (Odds Ratio = 0.89; 95%CI 0.82&#8315;0.98, p = 0.025; <sup>18</sup>F-FDG uptake measured as number of active slices)]. No trend was found for the association between CysC and characteristics of OCT-assessed coronary plaque vulnerability or CAC score. Conclusions: In patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), <sup>18</sup>F-FDG uptake in the DA was associated with a low level of serum CysC. There was no relation between CysC levels and OCT-assessed coronary plaque vulnerability or CAC score. These findings suggest that high levels of CysC may not be considered as independent markers of atherosclerosis.https://www.mdpi.com/2076-3417/9/4/657cystatin C<sup>18</sup>F-fluorodeoxyglucose-positron emission tomographyfrequency domain-optical coherence tomographycoronary artery calcium scorenon-ST-segment elevation acute coronary syndrome